Executive Moves

Executive Moves You Should Know About (September 03, 2025)

By Taylor-Dayne Davis

Last updated: Sep 3, 2025

Each week we explore some of the top executive moves across every industry and highlight them here. This week, we look at changes to the leadership team at OpenAI, Lululemon, Klaviyo and more.

OpenAI

OpenAI is shaking up its leadership under new Applications CEO Fidji Simo, fresh from Instacart. It’s snapping up analytics startup Statsig in a $1.1B deal, with founder Vijaye Raji stepping in as CTO of Applications to bolster products like ChatGPT and Codex, while Srinivas Narayanan is being elevated to CTO of B2B Apps. In a stride towards greater user safety, OpenAI is also set to launch parental controls for ChatGPT, addressing concerns about teen well-being. Read More

Lululemon

Lululemon is flexing its tech muscles, naming Ranju Das as its first Chief AI and Technology Officer starting September 2, 2025. With 20+ years across healthcare, fintech, and consumer tech, and a standout run as GM of Amazon AI Services, Das is set to power up innovation as CIO Julie Averill takes her final bow. Read More

Klaviyo

Chano Fernández, formerly of Eightfold.ai and Workday, Inc., has been appointed Interim Executive Officer at Klaviyo from September 1 to December 31, 2025. Reporting to CEO Andrew Bialecki, he joins during a pivotal period as the company sees strong revenue growth and improving cash flow but continues to face negative earnings and margin pressures. This leadership move marks a critical juncture for Klaviyo’s strategy and performance. Read More

Microsoft

Dave Citron, former Senior Director of Product at Google DeepMind, has joined Microsoft’s AI group as Corporate VP. His hire underscores Microsoft’s aggressive push to strengthen AI leadership under [Mustafa Suleyman], who is actively drawing top talent from his old Google stomping grounds. Read More

Crocs

Facing a $332 million loss in the first half of 2025, Crocs has named former Nike and SharkNinja exec Patraic Reagan as CFO after Susan Healy’s abrupt exit on August 28. Reporting to CEO Andrew Rees, Reagan will steer financial strategy and planning. On a lighter note, Crocs strutted into the Guinness World Records thanks to the “Croc King” and his nearly 4,000-pair collection—a quirky confidence booster for the brand. Read More

Nvidia

Warren Barkley, formerly General Manager at Microsoft and Head of Product for AI Initiatives at Google, has joined Nvidia as Vice President of Product Management. He brings experience kicking off Google’s GenAI pivot, where he doubled and tripled shipped features and drove non-linear adoption. Read More

T-Mobile

In a major leadership shake-up, Ulf Ewaldsson, President of Technology, and Callie Field, President of T-Mobile’s Business Group, are departing. John Saw, former EVP of Advanced and Emerging Technologies, will replace Ewaldsson, while board member Andre Almeida takes on Field’s responsibilities across broadband, T-Ads, financial services, enterprise, and government. These moves highlight T-Mobile’s push to strengthen its network and expand into new markets. Read More

Chipotle

After seven years, Chief Accounting and Administrative Officer Jamie McConnell is wrapping up her time at Chipotle to pursue a new professional opportunity. Her departure is on positive terms, with no disputes noted. Since joining in 2018, McConnell has brought experience from Rent-A-Center, Allergan, and Deloitte. Read More

Nestlé

Nestlé has dismissed CEO Laurent Freixe after just one year, citing an undisclosed relationship, adding to pressures from a share price slump, slowing sales, and U.S. tariffs. Philipp Navratil, head of Nespresso, has been appointed CEO to drive growth, strengthen M&A, and revitalize the business. The move marks another shift ahead of a planned chairman transition in 2026, underscoring a turbulent period for the food giant. Read More

CDC

Jim O’Neill, a former HHS official turned Silicon Valley investor with close ties to Peter Thiel, has been named acting CDC Director amid high-profile resignations and vaccine policy tensions. His lack of medical background and past drug approval views raise concerns, with a pivotal September vaccine advisory meeting set to be his first major test. Read More


Want more org charts? Sign up to The Org here!

In this article

The ORG helps
you hire great
candidates

Free to use – try today


Latest